688278 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Xiamen Amoytop Biotech Co. Ltd. engages in the research and development of genetic engineering technology. It develops recombinant protein drugs such as rHuGM-CSF, rHuG-CSF, rHuIL-11, rHuIFN a-2a and rHuIFN a-2b.The company's products include Molgramostim, Filgrastim, and Oprelvekin. Xiamen Amoytop Biotech was founded on August 7, 1996 and is and is headquartered in Xiamen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688278 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company